Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery

NCT04177953 is registered in ClinicalTrials.gov with Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest as lead sponsor.

NCT NCT04177953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04177953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery
Lead sponsor
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase
Phase 2
Overall status
Completed
Start date
February 4, 2019
Completion date
January 30, 2025
Enrollment
92 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

pleural mesothelioma malignant